Table 3

C3a(desArg) and TCC levels in plasma from HUS patients

nC3a(desArg) median, ng/mL (range)TCC median, AU/mL (range)
Acute phase 10* 465† (280-690) 5.8‡ (4.0-7.3) 
Recovery 10* 109 (72-180) 1.4 (0.7-2.4) 
Pediatric controls 6 90 (52-124) 0.98 (0.68-2.5) 
nC3a(desArg) median, ng/mL (range)TCC median, AU/mL (range)
Acute phase 10* 465† (280-690) 5.8‡ (4.0-7.3) 
Recovery 10* 109 (72-180) 1.4 (0.7-2.4) 
Pediatric controls 6 90 (52-124) 0.98 (0.68-2.5) 
*

Plasma samples analyzed from patients 1-10 (Table 1).

†

P < .01 and ‡P < .05 comparing plasma taken during the acute phase with pediatric controls. There was no significant difference between plasma taken after recovery and pediatric controls.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal